相关实验视频
Updated: May 13, 2025
08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
6.8K
背景,质量和复杂性:在免疫疗法治疗的癌症中精细理瘤突变负担
Noushin Niknafs1, Mimi Najjar2, Colum Dennehy2
1Johns Hopkins University, Baltimore, MD, United States.
概括
瘤突变负担 (TMB) 是癌症免疫疗法的生物标志物,但其预测价值受到技术和生物因素的限制. 根据突变质量和基因组景观校准TMB可以提高其临床实用性,用于预测免疫检查点抑制剂反应.
科学领域:
- 癌症基因组学 癌症基因组学
- 免疫疗法生物标志物
- 瘤突变负担 (TMB) 是指瘤突变负担.
背景情况:
- 瘤突变负担 (TMB) 是FDA批准的免疫检查点抑制剂 (ICI) 跨癌症的生物标志物.
- 由于技术和生物学限制,高TMB不能始终预测ICI反应.
研究的目的:
- 批判性地评估TMB在捕获ICI响应中的预测作用.
- 通过考虑突变子集和基因组景观来探索TMB的生物校准.
- 确定最大限度地提高TMB在癌症免疫治疗中的预测价值的策略.
主要方法:
- 在生物和技术层面对TMB进行剖析.
- 评估TMB在临床试验中的预测作用.
- 分析瘤异质性,纯度,采样方法,测序和算法.
- 考虑突变性过程和癌症血统依赖的共同突变模式.
主要成果:
- 技术变化和生物因素,如瘤异质性减弱TMB的预测价值.
- 生物校准,专注于免疫编辑突变和新抗原质量,提高TMB的实用性.
- 变异性过程和癌症血统影响TMB的解释.
结论:
- 标准化技术方法对于TMB至关重要.
- 在瘤基因组环境中解释TMB是最大限度地提高其对ICI反应的预测价值的关键.
- 生物校准TMB提供了一条改善免疫治疗结果预测的途径.
相关概念视频
01:27Tumor Immunotherapy
401
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
401
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K